Tesla, Inc.'s Q1 earnings beat lifts margins and FSD services, but TSLA valuation remains stretched with inventory risks. Click for this TSLA stock update.
Regeneron Pharmaceuticals, Inc. (REGN) Discusses C5 Complement Development Program Focusing on Cemdisiran and Pozelimab for Complement-Mediated Diseases ...
The integration of POET's technology into the Marvell ecosystem through the Celestial AI legacy creates a unique synergistic effect. Read more on what investors can expect from POET.
VictoryShares US Large Cap High Dividend Volatility-Weighted ETF (CDL) emerges as a top dividend growth ETF pick for its stable, low-volatility, large-cap US stock selection. Read more here.